Medigene AG buy MoneyMoney
Start price
05.09.17
/
50%
€13.67
Target price
24.01.18
€17.00
Performance (%)
25.09%
End price
24.01.18
€17.10
Summary
This prediction ended on 24.01.18 with a price of €17.10. The BUY prediction by MoneyMoney finished with a performance of 25.09%. MoneyMoney has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Medigene AG | -0.429% | -0.429% | -38.462% | -70.670% |
iShares Core DAX® | -0.116% | 1.953% | 14.155% | 16.268% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% | 43.377% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% | 8.501% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% | 41.752% |
According to MoneyMoney what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Significant cyclical dependencies
Comments by MoneyMoney for this prediction
In the thread Medigene AG diskutieren
Medigene
Übernahmefantasie bei den Biotech - Aktien ...
(Zielkurs erreicht)
Stopped prediction by MoneyMoney for Medigene AG
Medigene AG
Start price
Target price
Perf. (%)
€3.79
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-45.05%
23.02.23
23.02.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€14.12
09.04.18
09.04.18
€20.00
18.11.19
18.11.19
-58.75%
18.11.19
18.11.19
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€8.96
10.01.16
10.01.16
€13.00
28.12.16
28.12.16
33.93%
28.12.16
28.12.16
Could be worthwhile Investment >10% per year
Significant cyclical dependencies